Tokyo

London

New York

Register

Sign In

EUR/USD

1.1664

0.0036

0.31%

GBP/USD

1.2995

0.0029

0.23%

USD/JPY

111.13

-0.7425

-0.66%

USD/CHF

0.9459

-0.0056

-0.59%

EUR/GBP

0.8976

0.0008

0.08%

USD/CAD

1.2542

-0.0054

-0.43%

NZD/USD

0.7455

0.0052

0.71%

EUR/JPY

129.61

-0.4680

-0.36%

EUR/CHF

1.1033

-0.0031

-0.28%

AcelRx Pharmaceuticals Inc.

NASDAQ: ACRXHealthcare / Medical Appliances & Equipment / USA
3.20+0.10+3.23%Vol 825 0781Y Perf 7.14%
Jul 21st, 2017 16:00
BID3.15 ASK3.20
Open3.15 Previous Close3.10
Pre-Market- After-Trading3.15
 - -%  - -%
Target Price
8.00 
Analyst Rating
Moderate Buy 1.80
Potencial %
150.00 
Finscreener Ranking
—    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
—    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
—    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
—    -
Market Cap (mil)141 
Earnings Rating
Sell
Price Range Ratio 52wk %
58.69 
Earnings Date
27th Jul 2017

Today's Price Range

3.053.25

 

52wk Range

1.954.08

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Buy
Performance
1 Month
24.00%
3 Months
14.81%
6 Months
16.98%
1 Year
7.14%
3 Years
-69.12%
5 Years
-6.06%
Last Quotes
Name / TickerPriceChg.Chg.%
ACRX3.200.10003.23
AAPL150.27-0.0700-0.05
GOOG972.924.77000.49
MSFT73.79-0.4300-0.58
XOM80.12-0.7400-0.92
WFC54.17-0.7100-1.29
JNJ135.31-1.2600-0.92
FB164.43-0.1000-0.06
GE25.91-0.7800-2.92
JPM90.89-0.3100-0.34
...

TickerPriceChg.%52 Week High
CTAS138.439.19139.39
COF87.948.5596.92
ETFC41.635.1341.83
SYF30.874.5438.06
MCO132.574.25133.62
FITB26.182.7128.97
NFLX188.542.69191.50
KMX66.092.6669.11
VRTX163.172.41167.00
AAP105.271.98177.83
CCI99.171.95104.68
DFS62.531.8974.33
AEP69.981.8672.97
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 5.90
Current Ratio 6.10
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -2.80
Leverage Ratio -7.60
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin26.40
EBIT Margin-201.60
EBITDA Margin-190.00
Pre-tax Profit Margin-496.80
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 42.26
PS Ratios 8.44
Price to Cash Flow -
Price to Free Cash Flow -4.10
Cash Flow Per Share -0.68
Price to Tangible Book-5.54
Book Value per Share-0.43
Enterprise Value (in ths.)58 221
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-87.67
ROE last 12 Months -4 163.48
Return on Assets (5Y Avg) -28.15
ROA last 12 Months -47.27
Return on Capital (5Y Avg) -54.42
ROC last 12 Months -153.00
Return on invested Capital Q -
Return on invested Capital Y-90.89
Assets Turnover0.10
Receivables Turnover4.50
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)12 910
Revenue per Share 0.28
Revenue Growth 3 Years 2.08
Revenue Growth 5 Years 50.35
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q01 2017-0.28-0.34-21.43
Q04 2016-0.23-0.218.70
Q03 2016-0.24-0.25-4.17
Q02 2016-0.23-0.24-4.35
Q01 2016-0.22-0.220.00
Q04 2015-0.16-0.24-50.00
Q03 2015-0.220.11150.00
Q02 2015-0.26-0.2023.08
Earnings Per EndEstimateRevision %Trend
6/2017 QR-0.28-3.70Negative
9/2017 QR-0.270.00-
12/2017 FY-1.11-5.71Negative
12/2018 FY-0.83-16.90Negative
Next Report Date27th Jul 2017
Estimated EPS Next Report-0.28
Estimates Count5
EPS Growth Next 5 Years %0.00
Volume Overview
Volume825 078
Shares Outstanding (in ths.)45 380
Trades Count1 583
Dollar Volume2 556 426
Avg. Volume432 903
Avg. Weekly Volume3 511 415
Avg. Monthly Volume1 526 684
Avg. Quarterly Volume702 350

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

80%20%

Bearish Bullish

44%56%

Bearish Bullish

100%0%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (60.00 %)
3 (60.00 %)
3 (60.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (40.00 %)
2 (40.00 %)
2 (40.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
1.80
Moderate Buy
1.80
Moderate Buy
1.80

There are no comments yet.

News

Plus500
x